Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Melblez
Melblez
Delcath dives again on final FDA denial of liver cancer treatment
Mass Device
Mon, 09/16/13 - 11:19 am
Delcath
FDA
liver cancer
devices
Melblez
2013 FDA Drug Approval Calendar
TheStreet.com
Tue, 05/21/13 - 12:05 pm
drug approvals
GSK
Dolutegravir
Trametenib
Auxilium
Xiaflex
Delcath
Melblez
Seattle Genetics
Adcetris
Antares
Otrexup
Amag Pharmaceuticals
Feraheme
Cubist Pharmaceuticals
Entereg
Gilead
sofosbuvir
Amarin
Vascepa
Merck
suvorexant
Valeant Pharmaceuticals
efinaconazole
Depomed
Sefelsa
Zogenix
Zohydro
dabrafenib
tivozanib
Aveo Pharmaceuticals
FDA advisers recommend against Delcath's cancer therapy
Reuters
Fri, 05/3/13 - 08:59 am
FDA
advisory panels
Delcath
Melblez
Aveo, Delcath FDA Panel Live Blog
TheStreet.com
Thu, 05/2/13 - 10:52 am
FDA
advisory panels
tivozanib
Delcath
Aveo Oncology
kidney cancer
Melblez
Delcath Systems: Bullish On Melblez FDA Panel Vote And Subsequent Approval
Seeking Alpha
Fri, 03/8/13 - 11:10 am
Delcath
FDA
advisory panels
Melblez
ocular melanoma